Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

36.95
-0.9597-2.53%
Post-market: 36.950.00000.00%16:10 EDT
Volume:799
Turnover:29.62K
Market Cap:2.77M
PE:- -
High:37.04
Open:37.04
Low:36.95
Close:37.91
52wk High:45.88
52wk Low:25.71
Shares:75.00K
Float Shares:75.00K
Volume Ratio:0.71
T/O Rate:1.07%
Dividend:0.76
Dividend Rate:2.07%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Regeneron Exec Says Co Expects to Start Pivotal Study for Regn20423 Either in Late 2027 or Early 2028

THOMSON REUTERS
·
Oct 01

Regeneron Pharma Price Target Announced at $850.00/Share by Argus Research

Dow Jones
·
Oct 01

Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026

Reuters
·
Oct 01

Sanofi Exec Says "There is no Certainty at This Point in Time, but We are Actively Working in Order to Extend the Loss of Exclusivity of Dupixent"

THOMSON REUTERS
·
Oct 01

Sanofi CEO Says Expects the Market for Atopic Dermatitis Treatments to Nearly Double over the Next Five Years -Conf Call

THOMSON REUTERS
·
Oct 01

Vertex appoints Saha to Board of Directors

TIPRANKS
·
Oct 01

Press Release: Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Dow Jones
·
Oct 01

Regeneron Pharmaceuticals, Inc. : Argus Research Raises to Buy from Hold

THOMSON REUTERS
·
Oct 01

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Dow Jones
·
Oct 01

Sanofi’s Regeneron Fix Requires Extra Shot of M&A

Reuters
·
Oct 01

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Dow Jones
·
Oct 01

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Dow Jones
·
Oct 01

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Reuters
·
Oct 01

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
Oct 01

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
Oct 01

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
Oct 01

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS
·
Oct 01

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial

TIPRANKS
·
Oct 01